Key result
Antihypertensives and plasmapheresis improve GFR by ~38 mL/min in a malignant hypertension-induced TMA case.
Why the study?
In severe hypertension associated with TMA, establishing whether TMA is caused by malignant hypertension or conditions like TTP and HUS can be difficult.
Case Report (n=1)
In malignant hypertension-induced TMA, controlling hypertension can lead to the resolution of TMA and significant improvement in renal function over time.
Answers are grounded in this paper and cite their sources.
Renal recovery possible in malignant hypertension TMA with BP control plus plasmapheresis; leaves open need for controlled trials before practice change.
Malignant hypertension sometimes causes microangiopathic hemolytic anemia (MAHA) and thrombotic microangiopathy (TMA). TMA results in the obstruction of arterioles and capillaries due to microvascular thrombosis. The pathological diagnosis of TMA is done by tissue biopsy. In this process, malignant hypertension-induced TMA must be distinguished from thrombotic thrombocytopenic purpura (TTP) and hemolitic uremic syndrome (HUS). We describe the case of a 45-year-old man with malignant hypertension, MAHA, and severe renal failure. Plasmapheresis was performed until the ADAMTS -13 activity was reported as normal. The patient’s blood pressure was reduced in a controlled manner first using antihypertensives, and TMA was confirmed by a kidney biopsy. Based on the normal ADAMTS-13 (a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13) activity, other possible conditions that might cause TMA were eliminated, and malign hypertension-induced TMA was diagnosed. After two years, the glomerular filtration rate was found to have increased from 22 to 59.5 ml/min. In cases of severe hypertension associated with TMA, it may sometimes not be easy to establish whether TMA is caused by malignant hypertension or other associated diseases. The treatment of hypertension-induced TMA aims to control hypertension, which leads to the resolution of TMA over time. Cite this article as: Bora F, Yılmaz F, Sözel H, Akkaya B. A Case of Malignant Hypertension-Induced Thrombotic Microangiopathy with Gradually Improved Renal Function Using Appropriate Antihypertensives. Turk J Nephrol 2021; 30(1): 77-9.
No takes yet. Share an insight, caveat, or question.
Bora et al. (2021) conducted a case report in Malignant hypertension-induced thrombotic microangiopathy (n=1). Antihypertensives and plasmapheresis was evaluated on Glomerular filtration rate. In a 45-year-old man with malignant hypertension-induced thrombotic microangiopathy, treatment with antihypertensives and plasmapheresis increased glomerular filtration rate from 22 to 59.5 ml/min over two years.
Synapse has enriched 10 related papers. Consider them for comparative context: